This counter has probably gone

2
Comment
Favorite

This counter has probably gone under the radar by many investors. Been following it for 2 years, it's a gem waiting to shine

Clover Health Boosts 2024 Insurance Revenue Outlook, Lowers Medical Cost Ratio Range

Clover Health Investments pleased investors after Monday's closing bell by not only releasing Q2 results that beat on both lines, but also providing favorable updated 2024 guidance. The Medicare Advantage plan provider now sees full-year insurance revenue guidance of $1.35B-$1.375B up from $1.3B-$1.35B before. The medical cost ratio for 2024 is now expected at 77%-79%, down from 79%-81% prior. Clover Health was helped in the quarter by an 11% year-over-year increase in total revenue to $356.3M, as well as a medical cost ratio of 71.3%, compared to 77.2% in the year ago period.

Clover Health Boosts 2024 Insurance Revenue Outlook, Lowers Medical Cost Ratio Range

# Earnings & Estimates

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":335496080683016,"tweetId":"335496080683016","gmtCreate":1722944384940,"gmtModify":1722951516614,"author":{"id":4143078149508732,"authorId":4143078149508732,"authorIdStr":"4143078149508732","name":"NinjaDaddy","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.23","exceedPercentage":"80.27%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[{"themeId":"c0d77e622a6742cf8335299f8317b4b4","categoryId":"2929bb7468f5415f853fd96fb35d7c3b","name":"Earnings & Estimates","type":2,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/finance&rndata={\"themeId\":c0d77e622a6742cf8335299f8317b4b4}&rnconfig={\"headerBarHidden\": true}","description":"Earnings season is here. What's in focus?","image":"https://community-static.tradeup.com/news/dc18b55f50cc4b6c035031de21e3d6d2"}],"images":[],"coverImages":[],"html":"<html><head></head><body><p>This counter has probably gone under the radar by many investors. Been following it for 2 years, it's a gem waiting to shine&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>This counter has probably gone under the radar by many investors. Been following it for 2 years, it's a gem waiting to shine&nbsp;</p></body></html>","text":"This counter has probably gone under the radar by many investors. Been following it for 2 years, it's a gem waiting to shine","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/335496080683016","repostId":2457089410,"repostType":2,"repost":{"id":"2457089410","pubTimestamp":1722904917,"share":"https://www.laohu8.com/m/news/2457089410?lang=&edition=full","pubTime":"2024-08-06 08:41","market":"sg","language":"en","title":"Clover Health Boosts 2024 Insurance Revenue Outlook, Lowers Medical Cost Ratio Range","url":"https://stock-news.laohu8.com/highlight/detail?id=2457089410","media":"seekingalpha","summary":"Clover Health Investments  pleased investors after Monday's closing bell by not only releasing Q2 results that beat on both lines, but also providing favorable updated 2024 guidance. The Medicare Advantage plan provider now sees full-year insurance revenue guidance of $1.35B-$1.375B up from $1.3B-$1.35B before. The medical cost ratio for 2024 is now expected at 77%-79%, down from 79%-81% prior.  Clover Health was helped in the quarter by an 11% year-over-year increase in total revenue to $356.3M, as well as a medical cost ratio of 71.3%, compared to 77.2% in the year ago period.","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/CLOV\">Clover Health Investments</a> pleased investors after Monday&#39;s closing bell by not only releasing Q2 results that beat on both lines, but also providing favorable updated 2024 guidance.</p><p>Shares of Clover Health gained over 2% in extended trading.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/5a9c5d84fe8a57d68592d976038341cf\" tg-width=\"847\" tg-height=\"621\"/></p><p>The Medicare Advantage plan provider now sees full-year insurance revenue guidance of $1.35B-$1.375B up from $1.3B-$1.35B before. The medical cost ratio for 2024 is now expected at 77%-79%, down from 79%-81% prior.</p><p>Clover Health was helped in the quarter by an 11% year-over-year increase in total revenue to $356.3M, as well as a medical cost ratio of 71.3%, compared to 77.2% in the year ago period.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Clover Health Boosts 2024 Insurance Revenue Outlook, Lowers Medical Cost Ratio Range</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClover Health Boosts 2024 Insurance Revenue Outlook, Lowers Medical Cost Ratio Range\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-06 08:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4134517-clover-health-boosts-2024-insurance-revenue-outlook-lowers-medical-cost-ratio-range><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Clover Health Investments pleased investors after Monday's closing bell by not only releasing Q2 results that beat on both lines, but also providing favorable updated 2024 guidance.Shares of Clover ...</p>\n\n<a href=\"https://seekingalpha.com/news/4134517-clover-health-boosts-2024-insurance-revenue-outlook-lowers-medical-cost-ratio-range\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4547":"WSB热门概念","BK4154":"管理型保健护理","CLOV":"Clover Health Corp"},"source_url":"https://seekingalpha.com/news/4134517-clover-health-boosts-2024-insurance-revenue-outlook-lowers-medical-cost-ratio-range","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2457089410","content_text":"Clover Health Investments pleased investors after Monday's closing bell by not only releasing Q2 results that beat on both lines, but also providing favorable updated 2024 guidance.Shares of Clover Health gained over 2% in extended trading.The Medicare Advantage plan provider now sees full-year insurance revenue guidance of $1.35B-$1.375B up from $1.3B-$1.35B before. The medical cost ratio for 2024 is now expected at 77%-79%, down from 79%-81% prior.Clover Health was helped in the quarter by an 11% year-over-year increase in total revenue to $356.3M, as well as a medical cost ratio of 71.3%, compared to 77.2% in the year ago period.","news_type":1},"isVote":1,"tweetType":1,"viewCount":173,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":102,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}